You are about to leave doptelethcp.com and go to an external page.
Please note that Sobi is not responsible for the content of the website you are about to visit.
CONTINUEGo back
You are about to leave doptelethcp.com and go to an external page.
Please note that Sobi is not responsible for the content of the website you are about to visit.
CONTINUEGo back
This information is intended for healthcare professionals in the United States.
Are you a healthcare professional?
Yes
NoDiscover the Copay Assistance Program
Terms and Conditions
Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131
SHARING WITH COLORADO PRESCRIBERS
PRICING AND GENERIC EQUIVALENT INFORMATION
IN CONNECTION WITH PRESCRIPTION DRUG MARKETING
Pursuant to Colorado House Bill 19-1131 (and codified in Colorado Revised Statutes 12-42.5-308 and 12-280-308), the following information is being shared with Colorado prescribers (as defined by Colorado HB 19-1131) in connection with prescription drug marketing activities.
Prescription Drug Name: Doptelet® (avatrombopag)
Manufacturer Name: AkaRx, Inc., a wholly-owned subsidiary of Sobi, Inc.
Wholesale Acquisition Cost (WAC) of Doptelet® (avatrombopag): $392.01 (tablet)*
Generic Prescription Drugs from the same therapeutic class (as defined by HB 19-1131): None
IMPORTANT NOTES:
This website uses cookies. By continuing to use this website, you consent to our use of these cookies.